Safety and clinical activity of the histone deacetylase inhibitor givinostat in combination with meclorethamine in relapsed/refractory Hodgkin lymphoma (HL)

被引：1
|
作者：
Carlo-Stella, C.
Guidetti, A.
Viviani, S.
Bonfante, V.
Marchiano, A.
Gatti, B.
D'Urzo, C.
Di Nicola, M. A.
Corradini, P.
Gianni, A. M.
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Univ Milan, Milan, Italy
[3] Italfarmaco SpA, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.3068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3068
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A PHASE IB STUDY EVALUATING THE SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB COMBINED WITH OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA
    Palomba, M. L.
    Till, B. G.
    Park, S. I.
    Morschhauser, F.
    Cartron, G.
    Marks, R.
    Penuel, E.
    Chitra, S.
    Byon, J. C. H.
    Popplewell, L.
    HAEMATOLOGICA, 2016, 101 : 102 - 102
  • [42] Treatment of relapsed or refractory non-hodgkin lymphoma with the oral isotype-selective histone deacetylase inhibitor MGCD0103: Interim results from a phase II study
    Younes, A.
    Andreadis, C.
    Assouline, S.
    Rizzieri, D.
    Wedwood, A.
    McLaughlin, P.
    Laille, E.
    Li, Z.
    Martell, R. E.
    Crump, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 162 - 162
  • [43] Treatment of relapsed or refractory non-hodgkin lymphoma with the oral isotype-selective histone deacetylase inhibitor MGCD0103: Interim results from a phase II study
    Crump, M.
    Andreadis, C.
    Assouline, S.
    Rizzieri, D.
    Wedgwood, A.
    McLaughlin, P.
    Laille, E.
    Li, Z.
    Martell, R. E.
    Younes, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Interim results of a phase II multicenter study with the oral histone deacetylase inhibitor abexinostat in patients with relapsed/refractory follicular lymphoma.
    Gui, Lin
    Cheng, Ying
    Wang, Huaqing
    Cao, Junning
    Li, Zhenling
    Zhang, Lei
    Gao, Yuhuan
    Li, Yufu
    Xu, Weijie
    Li, Xiang
    Ke, Xiaoyan
    Jing, Hongmei
    Zhang, Qingyuan
    Xi, Yaming
    Liu, Tingbo
    Wang, Zhen
    Gao, Yajie
    Pan, Qin
    Zou, Liqun
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [46] The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models
    Maharaj, Lenushka
    Marson, Charles M.
    Middleton, Brian J.
    Rioja, Alf S.
    Perry, Jackie
    Oakervee, Heather
    Cavenagh, Jamie
    Joel, Simon P.
    Popat, Rakesh
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (01) : 135 - 139
  • [47] The optimal management of relapsed and refractory Hodgkin lymphoma: post - brentuximab and checkpoint inhibitor failure
    Grover, Natalie S.
    Dittus, Christopher
    Thakkar, Astha
    Beaven, Anne W.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 510 - 518
  • [48] Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
    Herrera, Alex F.
    Moskowitz, Alison J.
    Bartlett, Nancy L.
    Vose, Julie M.
    Ramchandren, Radhakrishnan
    Feldman, Tatyana A.
    LaCasce, Ann S.
    Ansell, Stephen M.
    Moskowitz, Craig H.
    Fenton, Keenan
    Ogden, Carol Anne
    Taft, David
    Zhang, Qu
    Kato, Kazunobu
    Campbell, Mary
    Advani, Ranjana H.
    BLOOD, 2018, 131 (11) : 1183 - 1194
  • [49] Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases
    de Forceville, L.
    Deau-Fischer, B.
    Franchi, P.
    Arsene-Henry, A.
    Mounat, T. Cassou
    Bouscary, D.
    Kirova, Y. M.
    CANCER RADIOTHERAPIE, 2019, 23 (03): : 232 - 239
  • [50] Is there a place for the combination of brentuximab vedotin and bendamustine in treatment of patients with relapsed/refractory Hodgkin lymphoma?
    Chen, Robert W.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
12345